-
-
-
-
-
-
-
FDA accepts Kowa's glaucoma eye drop application, sets 2027 review date
-
-
-
-
-
-
-
BofA Securities Starts Apnimed Inc (APMD) at Buy
-
-
-
-
-
-
-
Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
-
-
-
-
-
-
-
FDA grants accelerated approval to Bristol Myers Squibb's Zenbexus
-
-
-
-
-
-
-
China approves ivonescimab plus chemo for squamous NSCLC
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $275 at Guggenheim
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised at TD Cowen Following 'Nice Topline Beat And Raise'
-
15,740 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

